ArticleCardiovascular drugs and therapy2026

Superior Cerebrovascular Outcomes with Tirzepatide Versus Semaglutide: A Call for Cautious Interpretation of Observational Data.

Artur Dziewierz et al.PubMed ↗Publisher ↗

No numbers read from the abstract.